Therefore, intervening in the thrombo-inflammatory cascade might be a promising synergistic approach (e.g., anticoagulation and a pleiotropic, anti-inflammatory effect on CD8+ T cells) to reduce the disease progression of AF. The gene discussed is CD8A; the disease is atrial fibrillation.